Vytrus Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	98	16	13	23	-	-
Market Cap Growth	387.66%	29.02%	-46.26%	-	-	-
Enterprise Value	96	16	14	23	-	-
Last Close Price	13.00	2.16	1.86	3.40	-	-
PE Ratio	50.10	15.95	23.17	38.81	-	-
Forward PE	37.05	21.98	11.97	26.21	-	-
PS Ratio	12.10	2.67	2.69	5.24	-	-
PB Ratio	10.99	2.23	2.38	4.94	-	-
P/TBV Ratio	21.69	5.06	7.59	14.68	-	-
P/FCF Ratio	36.22	9.35	16.55	38.78	-	-
P/OCF Ratio	33.06	8.83	13.96	22.90	-	-
EV/Sales Ratio	11.87	2.64	2.91	5.20	-	-
EV/EBITDA Ratio	40.48	13.67	22.96	30.92	-	-
EV/EBIT Ratio	45.60	16.34	33.82	38.42	-	-
EV/FCF Ratio	35.53	9.24	17.93	38.49	-	-
Debt / Equity Ratio	0.16	0.24	0.39	0.21	0.22	0.24
Debt / EBITDA Ratio	0.60	1.51	3.49	1.31	0.94	1.47
Debt / FCF Ratio	0.53	1.02	2.72	1.63	4.09	-
Net Debt / Equity Ratio	-0.21	-0.10	0.18	0.06	-0.08	-0.06
Net Debt / EBITDA Ratio	-0.79	-0.64	1.63	0.35	-0.36	-0.38
Net Debt / FCF Ratio	-0.69	-0.43	1.27	0.43	-1.56	0.71
Asset Turnover	0.68	0.60	0.54	0.59	0.53	0.39
Inventory Turnover	1.53	1.07	0.72	1.02	1.11	0.59
Quick Ratio	2.79	2.60	1.90	0.99	1.92	2.03
Current Ratio	3.08	3.03	2.46	1.33	2.26	2.39
Return on Equity (ROE)	24.85%	16.23%	10.85%	13.44%	11.45%	6.15%
Return on Assets (ROA)	11.04%	6.02%	2.92%	4.99%	3.82%	2.15%
Return on Capital Employed (ROCE)	18.30%	10.00%	4.90%	9.00%	6.40%	3.50%
Earnings Yield	2.00%	6.27%	4.32%	2.58%	-	-
FCF Yield	2.76%	10.70%	6.04%	2.58%	-	-
Buyback Yield / Dilution	-	-11.71%	-	-	-0.43%	0.92%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.